{"nct_id":"NCT00046683","title":"Efficacy/Safety of Frontline Alemtuzumab (Campath, MabCampath) vs Chlorambucil in Patients With Progressive B-Cell Lymphocytic Leukemia","status":"COMPLETED","status_verified_date":"2016-07","start_date":"2001-07","start_date_type":null,"primary_completion_date":null,"primary_completion_date_type":null,"completion_date":"2006-06","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["SNY"]}